NovaBay Pharmaceuticals: A Potential Bargain With Catalysts Pending - Seeking Alpha, 6/13/2012 9:47:00 AM

NovaBay's Mid-Week Move: A Hint Of More To Come? - Seeking Alpha, 6/7/2012 3:21:00 AM

InPlay: NovaBay Pharma announces successful end-of-Phase 2a FDA meeting for dermatology program - Yahoo, 6/6/2012 7:06:00 AM

NovaBay Announces Successful End-of-Phase 2a FDA Meeting for Dermatology Program - GlobeNewswire, 6/6/2012 7:00:00 AM

NovaBay Ocular Trial Taps Broad Activity Of Its Anti-Infective - Seeking Alpha, 5/30/2012 7:10:00 AM

0
NovaBay's Market Cap Doesn't Adequately Value Pipeline Potential - Seeking Alpha, 5/22/2012 6:54:00 PM


Weekly Stock Watch: May 21-25 - Seeking Alpha, 5/21/2012 7:13:00 AM

NovaBay Enrolls First Patients in Global BAYnovation(TM) Phase 2b Study for Adenoviral Conjunctivitis - GlobeNewswire, 5/17/2012 7:00:00 AM

NOVABAY PHARMACEUTICALS, INC. Financials - Yahoo, 5/12/2012 1:04:00 PM

NovaBay Pharmaceuticals Provides Q1 - 2012 Financial Results - GlobeNewswire, 5/3/2012 8:05:00 AM

NOVABAY PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report - Yahoo, 5/3/2012 8:03:00 AM


NovaBay's Aganocide Outperformed Antibiotics In Study - Seeking Alpha, 5/3/2012 7:45:00 AM

NovaBay: Tomorrow's Staple In Antimicrobial Therapy? - Seeking Alpha, 5/2/2012 4:54:00 PM

NovaBay's Aganocide Out-Performed Traditional Antibiotics in Drug Resistance Study - GlobeNewswire, 5/2/2012 7:30:00 AM

NovaBay's NeutroPhase(R) Supports Healing of Chronic Wounds - GlobeNewswire, 4/19/2012 7:30:00 AM

NovaBay to Present New Case Studies on NeutroPhase(R) at the 2012 Spring Symposium on Advanced Wound Care - GlobeNewswire, 4/16/2012 7:30:00 AM